e-learning
resources
Virtual 2021
06.09.2021
Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical spectrum and outcome of non IPF patients with a typical UIP picture
J. Naftel (Portsmouth, United Kingdom), M. Mottershaw (Portsmouth, United Kingdom), K. Strickland (Portsmouth, United Kingdom), A. Wallis (Portsmouth, United Kingdom), P. Mcparland (Portsmouth, United Kingdom), A. Donaldson (Portsmouth, United Kingdom), S. Babu (Portsmouth, United Kingdom)
Source:
Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Session:
Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Session type:
E-poster
Number:
2248
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Naftel (Portsmouth, United Kingdom), M. Mottershaw (Portsmouth, United Kingdom), K. Strickland (Portsmouth, United Kingdom), A. Wallis (Portsmouth, United Kingdom), P. Mcparland (Portsmouth, United Kingdom), A. Donaldson (Portsmouth, United Kingdom), S. Babu (Portsmouth, United Kingdom). Clinical spectrum and outcome of non IPF patients with a typical UIP picture. 2248
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Clinical and radiological features of 22 patients with NSIP
Source: Eur Respir J 2007; 30: Suppl. 51, 577s
Year: 2007
Clinical features and prognosis of Chinese sarcoidosis patients.
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Clinical significance of histological UIP pattern in interstitial pneumonia with autoimmune features (IPAF)
Source: International Congress 2017 – Novel and old entities
Year: 2017
Prognostic determinants in IPF patients with the histological features of usual interstitial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 526s
Year: 2001
Clinical features and outcomes of patients with myositis associated-interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Do typical and atypical HRCT patterns make difference in prognosis of patients with IPF?
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Comparing clinical features of cases with bronchiectasis on acute and stable term
Source: Eur Respir J 2005; 26: Suppl. 49, 305s
Year: 2005
Clinical characteristics and prognosis of fibrotic nonspecific interstitial pneumonia
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
The features of patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 436s
Year: 2002
The features of sarcoidosis in owerweight patients.
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021
Clinical characteristics of 112 patients with bronchiectasis
Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach
Year: 2010
Clinical presentation on nonspecific (NSIP) compared to usual (UIP) interstitial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 526s
Year: 2001
Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Clinical features of COVID-19 pneumonia in elderly patients
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia
Source: International Congress 2017 – Lung function testing
Year: 2017
Clinical description of a population of Dutch IPF patients
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Comparison of clinical characteristics between stable COPD patients with- and without mild bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 257s
Year: 2002
Comparison of clinical features in patients with cystic fibrosis according to the age at diagnosis
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept